Back to search

University of Patras

Μορφολογική μελέτη της έκφρασης του οιστρογονικού υποδοχέα β (ERβ), συν-ρυθμιστών της μεταγραφής και πιθανών δεικτών καρκινικών stem κυττάρων σε αστροκυτταρικούς όγκους εγκεφάλου: μια συστημική προσέγγιση

Abstract

dc:description

Astrocytic tumors are the most common primary neoplasms of the central nervous system (CNS) and have traditionally been associated with disappointing clinical outcomes. The current challenge is to develop more efficacious and targeted therapeutic paradigms, exploiting the knowledge derived from the systems approach of understanding the complex networks underlying tumor formation and progression. Estrogen receptor beta (ERβ) and co-regulators of transcription AIB1, TIF2 and PELP1, are key components of complex cellular networks and integrate diverse signaling afferents with transcription programs controlling various physiological cellular processes and a variety of disease states including cancer. SOX2 and EZH2 represent crucial components of the reciprocal regulatory circuit that controls stemness. Elucidating the behavior of this particular network in cancer and its role in the formation of putative cancer stem cells is considered essential for the understanding of cancer as an adaptive complex system and subsequently allowing the discovery of more successful therapeutic designs. Purpose. In the context of the systems approach of comprehending tumorigenesis in astrocytomas, we sought to investigate the expression of ERβ and co – regulatory proteins AIB1, TIF1 and PELP1, as well as parallel expression of SOX2 and EZH2 in astrocytomas of various grades, and correlate the protein expression profiles with clinicopathological parameters and patients’ prognosis. Materials and methods. Expression of ERβ, AIB1, TIF2, PELP1, EZH2 and SOX2 was evaluated in 86 cases of astrocytic tumors, using Immunohistochemistry, on formalin-fixed paraffin-embedded tissue sections. Twenty grade II astrocytomas, 22 grade III anaplastic astrocytomas and 46 grade IV glioblastomas multiform (GBM) were included in this study. Polymer based technique (Envision, Dako, CA, USA) or MACH4 Universal HRP-Polymer Detection (Bio care Medical, CA, USA) and primary antibodies against ERβ1 (Biogenex, CA, USA), AIB1 (BD Biosciences, Ca, USA), TIF2 (BD Biosciences, Ca, USA), PELP-1/MNAR (Novus Biologicals, CO, USA) EZH2 (Novocastra, UK) and SOX2 (R&D Systems, Inc.) were used. In each case, the percentage of cells exhibiting positive staining was determined. Representative areas were selected at low power (x100) magnification. Cell counts were performed at a 400X magnification. Data were analyzed using the SPSS statistical package (SPSS©, Release 17.0, Chicago, IL, USA). The level of significance was set at p-value <0.05. Results. ERβ levels were significantly decreased with the progression of tumors’ grade. High expression of ERβ was an independent favorable prognostic factor on multivariate analysis. Expression of AIB1, TIF2 and PELP1, was not correlated to ERβ expression and followed an opposite trend, with increasing levels in grade III and IV relative to grade II tumors. Univariate survival analysis revealed that high AIB1, TIF2 and PELP1 expression was associated with worse prognosis. Statistical analysis further revealed significantly higher expression of EZH2 and SOX2 in high grade III and IV astrocytomas, compared to low grade II astrocytomas. Strong correlation between EZH2 and SOX2 was also detected within all subgroups according to grade. Kaplan-Meier showed that EZH2 and SOX2 high expression was predictive of worse overall survival in the whole cohort as well as after subgroup analysis by grade. Finally, multivariate Cox analysis that included age, gender, grade, and expression of both proteins, revealed that high EZH2 together with higher grade were strong negative prognostic factors. Conclusions. ERβ, AIB1, TIF2 and PELP1 appear to play an important role in the pathogenesis of astrocytic tumors, with ERβ exhibiting a protective effect, whereas AIB1, TIF2 and PELP1 facilitate malignant progression. AIB1, TIF2 και PELP1 contribution in tumor progression is speculated to be achieved through ERβ independent pathways. Moreover, the expression status of ERβ, by distinguish patient subpopulations with different prognosis within the same grade, could be a useful tool accommodating personalized clinical decision-making. EZH2 and SOX2 may serve as potential cancer stem cell markers in astrocytomas and as such help optimizing diagnostic and prognostic assessments and devising novel individually tailored treatment strategies.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kefalopoulou, Zinovia-Maria
  • Κεφαλοπούλου, Ζηνοβία-Μαρία

Subjects

dc:subject × 9

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27939

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kefalopoulou, Zinovia-Maria; Κεφαλοπούλου, Ζηνοβία-Μαρία. Μορφολογική μελέτη της έκφρασης του οιστρογονικού υποδοχέα β (ERβ), συν-ρυθμιστών της μεταγραφής και πιθανών δεικτών καρκινικών stem κυττάρων σε αστροκυτταρικούς όγκους εγκεφάλου: μια συστημική προσέγγιση. University of Patras, 2012. http://hdl.handle.net/10442/hedi/27939